1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct-Access Genetic Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Diagnostic Screening
1.2.3 PGD
1.2.4 Relationship testing
1.3 Market by Application
1.3.1 Global Direct-Access Genetic Testing Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Direct-Access Genetic Testing Market Perspective (2018-2032)
2.2 Direct-Access Genetic Testing Growth Trends by Region
2.2.1 Direct-Access Genetic Testing Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Direct-Access Genetic Testing Historic Market Size by Region (2018-2023)
2.2.3 Direct-Access Genetic Testing Forecasted Market Size by Region (2023-2032)
2.3 Direct-Access Genetic Testing Market Dynamics
2.3.1 Direct-Access Genetic Testing Industry Trends
2.3.2 Direct-Access Genetic Testing Market Drivers
2.3.3 Direct-Access Genetic Testing Market Challenges
2.3.4 Direct-Access Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Direct-Access Genetic Testing Players by Revenue
3.1.1 Global Top Direct-Access Genetic Testing Players by Revenue (2018-2023)
3.1.2 Global Direct-Access Genetic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Direct-Access Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Direct-Access Genetic Testing Revenue
3.4 Global Direct-Access Genetic Testing Market Concentration Ratio
3.4.1 Global Direct-Access Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct-Access Genetic Testing Revenue in 2022
3.5 Direct-Access Genetic Testing Key Players Head office and Area Served
3.6 Key Players Direct-Access Genetic Testing Product Solution and Service
3.7 Date of Enter into Direct-Access Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Direct-Access Genetic Testing Breakdown Data by Type
4.1 Global Direct-Access Genetic Testing Historic Market Size by Type (2018-2023)
4.2 Global Direct-Access Genetic Testing Forecasted Market Size by Type (2023-2032)
5 Direct-Access Genetic Testing Breakdown Data by Application
5.1 Global Direct-Access Genetic Testing Historic Market Size by Application (2018-2023)
5.2 Global Direct-Access Genetic Testing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Direct-Access Genetic Testing Market Size (2018-2032)
6.2 North America Direct-Access Genetic Testing Market Size by Country (2018-2023)
6.3 North America Direct-Access Genetic Testing Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Direct-Access Genetic Testing Market Size (2018-2032)
7.2 Europe Direct-Access Genetic Testing Market Size by Country (2018-2023)
7.3 Europe Direct-Access Genetic Testing Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Direct-Access Genetic Testing Market Size (2018-2032)
8.2 Asia-Pacific Direct-Access Genetic Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Direct-Access Genetic Testing Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Direct-Access Genetic Testing Market Size (2018-2032)
9.2 Latin America Direct-Access Genetic Testing Market Size by Country (2018-2023)
9.3 Latin America Direct-Access Genetic Testing Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Direct-Access Genetic Testing Market Size (2018-2032)
10.2 Middle East & Africa Direct-Access Genetic Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Direct-Access Genetic Testing Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Direct-Access Genetic Testing Introduction
11.1.4 23andMe Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.1.5 23andMe Recent Development
11.2 MyHeritage
11.2.1 MyHeritage Company Detail
11.2.2 MyHeritage Business Overview
11.2.3 MyHeritage Direct-Access Genetic Testing Introduction
11.2.4 MyHeritage Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.2.5 MyHeritage Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Detail
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Direct-Access Genetic Testing Introduction
11.3.4 LabCorp Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.3.5 LabCorp Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Detail
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Direct-Access Genetic Testing Introduction
11.4.4 Myriad Genetics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.4.5 Myriad Genetics Recent Development
11.5 Ancestry.com
11.5.1 Ancestry.com Company Detail
11.5.2 Ancestry.com Business Overview
11.5.3 Ancestry.com Direct-Access Genetic Testing Introduction
11.5.4 Ancestry.com Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.5.5 Ancestry.com Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Direct-Access Genetic Testing Introduction
11.6.4 Quest Diagnostics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 Gene By Gene
11.7.1 Gene By Gene Company Detail
11.7.2 Gene By Gene Business Overview
11.7.3 Gene By Gene Direct-Access Genetic Testing Introduction
11.7.4 Gene By Gene Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.7.5 Gene By Gene Recent Development
11.8 DNA Diagnostics Center
11.8.1 DNA Diagnostics Center Company Detail
11.8.2 DNA Diagnostics Center Business Overview
11.8.3 DNA Diagnostics Center Direct-Access Genetic Testing Introduction
11.8.4 DNA Diagnostics Center Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.8.5 DNA Diagnostics Center Recent Development
11.9 Invitae
11.9.1 Invitae Company Detail
11.9.2 Invitae Business Overview
11.9.3 Invitae Direct-Access Genetic Testing Introduction
11.9.4 Invitae Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.9.5 Invitae Recent Development
11.10 IntelliGenetics
11.10.1 IntelliGenetics Company Detail
11.10.2 IntelliGenetics Business Overview
11.10.3 IntelliGenetics Direct-Access Genetic Testing Introduction
11.10.4 IntelliGenetics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.10.5 IntelliGenetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Direct-Access Genetic Testing Introduction
11.11.4 Ambry Genetics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.11.5 Ambry Genetics Recent Development
11.12 Living DNA
11.12.1 Living DNA Company Detail
11.12.2 Living DNA Business Overview
11.12.3 Living DNA Direct-Access Genetic Testing Introduction
11.12.4 Living DNA Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.12.5 Living DNA Recent Development
11.13 EasyDNA
11.13.1 EasyDNA Company Detail
11.13.2 EasyDNA Business Overview
11.13.3 EasyDNA Direct-Access Genetic Testing Introduction
11.13.4 EasyDNA Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.13.5 EasyDNA Recent Development
11.14 Pathway Genomics
11.14.1 Pathway Genomics Company Detail
11.14.2 Pathway Genomics Business Overview
11.14.3 Pathway Genomics Direct-Access Genetic Testing Introduction
11.14.4 Pathway Genomics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.14.5 Pathway Genomics Recent Development
11.15 Centrillion Technology
11.15.1 Centrillion Technology Company Detail
11.15.2 Centrillion Technology Business Overview
11.15.3 Centrillion Technology Direct-Access Genetic Testing Introduction
11.15.4 Centrillion Technology Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.15.5 Centrillion Technology Recent Development
11.16 Xcode
11.16.1 Xcode Company Detail
11.16.2 Xcode Business Overview
11.16.3 Xcode Direct-Access Genetic Testing Introduction
11.16.4 Xcode Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.16.5 Xcode Recent Development
11.17 Color Genomics
11.17.1 Color Genomics Company Detail
11.17.2 Color Genomics Business Overview
11.17.3 Color Genomics Direct-Access Genetic Testing Introduction
11.17.4 Color Genomics Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.17.5 Color Genomics Recent Development
11.18 Anglia DNA Services
11.18.1 Anglia DNA Services Company Detail
11.18.2 Anglia DNA Services Business Overview
11.18.3 Anglia DNA Services Direct-Access Genetic Testing Introduction
11.18.4 Anglia DNA Services Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.18.5 Anglia DNA Services Recent Development
11.19 African Ancestry
11.19.1 African Ancestry Company Detail
11.19.2 African Ancestry Business Overview
11.19.3 African Ancestry Direct-Access Genetic Testing Introduction
11.19.4 African Ancestry Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.19.5 African Ancestry Recent Development
11.20 Canadian DNA Services
11.20.1 Canadian DNA Services Company Detail
11.20.2 Canadian DNA Services Business Overview
11.20.3 Canadian DNA Services Direct-Access Genetic Testing Introduction
11.20.4 Canadian DNA Services Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.20.5 Canadian DNA Services Recent Development
11.21 DNA Family Check
11.21.1 DNA Family Check Company Detail
11.21.2 DNA Family Check Business Overview
11.21.3 DNA Family Check Direct-Access Genetic Testing Introduction
11.21.4 DNA Family Check Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.21.5 DNA Family Check Recent Development
11.22 Alpha Biolaboratories
11.22.1 Alpha Biolaboratories Company Detail
11.22.2 Alpha Biolaboratories Business Overview
11.22.3 Alpha Biolaboratories Direct-Access Genetic Testing Introduction
11.22.4 Alpha Biolaboratories Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.22.5 Alpha Biolaboratories Recent Development
11.23 Test Me DNA
11.23.1 Test Me DNA Company Detail
11.23.2 Test Me DNA Business Overview
11.23.3 Test Me DNA Direct-Access Genetic Testing Introduction
11.23.4 Test Me DNA Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.23.5 Test Me DNA Recent Development
11.24 23 Mofang
11.24.1 23 Mofang Company Detail
11.24.2 23 Mofang Business Overview
11.24.3 23 Mofang Direct-Access Genetic Testing Introduction
11.24.4 23 Mofang Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.24.5 23 Mofang Recent Development
11.25 Genetic Health
11.25.1 Genetic Health Company Detail
11.25.2 Genetic Health Business Overview
11.25.3 Genetic Health Direct-Access Genetic Testing Introduction
11.25.4 Genetic Health Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.25.5 Genetic Health Recent Development
11.26 DNA Services of America
11.26.1 DNA Services of America Company Detail
11.26.2 DNA Services of America Business Overview
11.26.3 DNA Services of America Direct-Access Genetic Testing Introduction
11.26.4 DNA Services of America Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.26.5 DNA Services of America Recent Development
11.27 Shuwen Health Sciences
11.27.1 Shuwen Health Sciences Company Detail
11.27.2 Shuwen Health Sciences Business Overview
11.27.3 Shuwen Health Sciences Direct-Access Genetic Testing Introduction
11.27.4 Shuwen Health Sciences Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.27.5 Shuwen Health Sciences Recent Development
11.28 Mapmygenome
11.28.1 Mapmygenome Company Detail
11.28.2 Mapmygenome Business Overview
11.28.3 Mapmygenome Direct-Access Genetic Testing Introduction
11.28.4 Mapmygenome Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.28.5 Mapmygenome Recent Development
11.29 Full Genomes
11.29.1 Full Genomes Company Detail
11.29.2 Full Genomes Business Overview
11.29.3 Full Genomes Direct-Access Genetic Testing Introduction
11.29.4 Full Genomes Revenue in Direct-Access Genetic Testing Business (2018-2023)
11.29.5 Full Genomes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
